Personalized medicine Europe: Health, genes and society: Tel-Aviv University, Tel-Aviv, Israel, June 19 -21, 2005

David Gurwitz, Gregory Livshits

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

In summary, we believe that pharmacogenetics will not replace, but enhance, existing good medical practice. A deliberate approach starts with investing more in studies aimed at clarifying relations between genotypes and drug response phenotypes (both safety and efficacy), educating healthcare professionals by illustrating the benefits of pharmacogenomics, and by educating society about the potential benefits for healthcare from the new genomics and proteomics technologies. We feel that the Tel-Aviv workshop on personalized medicine has provided a competent venue for this theme.

Original languageEnglish
Pages (from-to)376-380
Number of pages5
JournalEuropean Journal of Human Genetics
Volume14
Issue number3
DOIs
StatePublished - Mar 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Personalized medicine Europe: Health, genes and society: Tel-Aviv University, Tel-Aviv, Israel, June 19 -21, 2005'. Together they form a unique fingerprint.

Cite this